Find a Tender
complete
Official procurement procedure
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.
Pharmaceutical products
UK
Published value
Not published
Submission deadline Not published
Lots published4
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: The NHS Commissioning Board (operating under the name of NHS England): "NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.". Published status: complete. Published value: Value not published. 4 published lots. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | The NHS Commissioning Board (operating under the name of NHS England) | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: The NHS Commissioning Board (operating under the name of NHS England)
Market Analytics
Derived from OCDS awards & bid statistics
Published history for The NHS Commissioning Board (operating under the name of NHS England). These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Competition Density
46Bids / Report
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate availablePayment Terms
Check noticePublished terms
Coverage: 829 active published awards; 827 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityThe NHS Commissioning Board (operating under the name of NHS England) | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published23 Feb 2021, 13:53 GMT | Last source update23 Feb 2021, 13:53 GMT | Recurring procurementNot published |
ClassificationPharmaceutical products | ||
Delivery area UK | ||
OCIDocds-h6vhtk-029565 | ||
What is being bought
CM/PHR/20/5591/01 - Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/20/5591/02 - Midlands and East Branded Medicines – Annual Tranche, Cytokine Modulators, other monoclonal antibodies Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma. Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 monthsCM/PHR/20/5591/03 – Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to Pan London. Period of framework: 1 March 2021 to 31 August 2021CM/PHR/20/5591/04 – Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to South of England. Period of framework: 1 March 2021 to 31 August 2021
What changed
From the official release history
- Status changed to complete
23 Feb 2021, 13:53 GMT - Official notice release published
23 Feb 2021, 13:53 GMT - Buyer information updated
23 Feb 2021, 13:53 GMT
Lots and requirements (4)
Published by the contracting authority
- Lot 1 · #1Lot 1: Midlands and East (MAE) Tranche BcancelledPublished valueNot publishedCM/PHR/20/5591/01 - NHS Framework for the Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 2 · #2Lot 2: Midlands and East Cytokine Modulators and other monoclonal antibodiescancelledPublished valueNot publishedCM/PHR/20/5591/02 - NHS Framework for the Midlands and East Branded Medicines – Annual Tranche, Cytokine Modulators, other monoclonal antibodies Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma. Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 3 · #3Lot 3: (LNW) – Interleukin Inhibitors, JAK Inhibitors, Migraine & AsthmacancelledPublished valueNot publishedCM/PHR/20/5591/03 – NHS Framework agreement for the supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to Pan London. Period of framework: 1 March 2021 to 31 August 2021. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
- Lot 4 · #4Lot 4: (SOFE) – Interleukin Inhibitors, JAK Inhibitors, Migraine & AsthmacancelledPublished valueNot publishedCM/PHR/20/5591/04 – NHS Framework agreement for the supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to South of England. Period of framework: 1 March 2021 to 31 August 2021. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documentsContract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
23 Feb 2021, 13:53 GMT - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Award active
Not published · Not published - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1 - Contract active
Signed 25 Jan 2021, 00:00 GMT · £1
Commercial outcome and competition
Awards Accord-UK Ltd Not published · Not published · active Dr.Reddy's Laboratories (UK) Limited Not published · Not published · active Eli Lilly and Company Ltd Not published · Not published · active LEO Pharma Not published · Not published · active Ferring Pharmaceuticals Ltd Not published · Not published · active Gilead Sciences Limited Not published · Not published · active Ipsen Not published · Not published · active Merck Serono Limited Not published · Not published · active Merck Sharpe and Dohme (UK) Limited Not published · Not published · active Mylan Not published · Not published · active Napp Pharmaceuticals Ltd Not published · Not published · active Aventis Pharma ltd t/a Sanofi Not published · Not published · active Novo Nordisk Not published · Not published · active Roche Products Ltd Not published · Not published · active ROVI Biotech Ltd Not published · Not published · active Novartis Pharmaceuticals UK Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Sandoz Ltd Not published · Not published · active Techdow Pharma England Ltd Not published · Not published · active Takeda UK Ltd Not published · Not published · active Teva UK Limited Not published · Not published · active UL Global Pharma Not published · Not published · active Bayer Ltd Not published · Not published · active Bristol Myers Squibb Not published · Not published · active Celltrion Healthcare United Kingdom Limited Not published · Not published · active Eli Lilly and Company Ltd Not published · Not published · active AstraZeneca Not published · Not published · active Merck Sharpe and Dohme (UK) Limited Not published · Not published · active Napp Pharmaceuticals Ltd Not published · Not published · active Novartis Pharmaceuticals UK Ltd Not published · Not published · active Pfizer Ltd Not published · Not published · active Roche Products Ltd Not published · Not published · active Teva UK Limited Not published · Not published · active Biogen Not published · Not published · active Takeda UK Ltd Not published · Not published · active Amgen Ltd Not published · Not published · active Gedeon Richter UK Ltd Not published · Not published · active Thornton and Ross Ltd Not published · Not published · active UCB Pharma Ltd Not published · Not published · active Janssen-Cilag Ltd Not published · Not published · active Merck Sharp and Dohme (MSD) Not published · Not published · active Sobi (Swedish Orphan Biovitrum Ltd) Not published · Not published · active Eli Lilly and Company Ltd Not published · Not published · active AstraZeneca Not published · Not published · active Bristol Myers Squibb Not published · Not published · active Teva UK Limited Not published · Not published · active Sobi (Swedish Orphan Biovitrum Ltd) Not published · Not published · active Eli Lilly and Company Ltd Not published · Not published · active Novartis Pharmaceuticals UK Ltd Not published · Not published · active Teva UK Limited Not published · Not published · active |
Contracts Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active Contract £1 · signed 25 Jan 2021, 00:00 GMT · active |
Bid statistics bids: 30 bids: 6 bids: 7 bids: 7 bids: 7 bids: 7 bids: 30 bids: 7 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 30 bids: 6 bids: 6 bids: 6 smeBids: 11 smeBids: 1 smeBids: 1 smeBids: 1 smeBids: 1 smeBids: 1 smeBids: 1 smeBids: 1 smeBids: 11 smeBids: 11 smeBids: 11 smeBids: 11 |
Buyer and organisations in this procedure
The NHS Commissioning Board (operating under the name of NHS England)
Contracting authority GB-FTS-2505Documents (0)
Official links; attachments are not copied
No linked documents are published
Related procedures (0)
No related procedures published